Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
15:26:38 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 147.29 USD | -1.01% |
|
+2.37% | +69.16% |
| Market Cap | 9.63B 8.28B 7.77B 7.11B 13.28B 910B 13.38B 91.97B 35.82B 465B 36.16B 35.37B 1,498B | P/E 2026 * |
32x | P/E 2027 * | -314x |
|---|---|---|---|---|---|
| Enterprise Value | 9.09B 7.82B 7.34B 6.72B 12.53B 859B 12.63B 86.83B 33.81B 439B 34.14B 33.39B 1,414B | EV / Sales 2026 * |
16.8x | EV / Sales 2027 * | 44.8x |
| Free-Float |
97.68% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTGX | Delayed | |
CBOE
| PTGX | Real-time | |
|
Tradegate
| PGF | Real-time |
Last Transcript : Protagonist Therapeutics, Inc.
| 1 day | -0.93% | ||
| 1 week | +2.37% | ||
| Current month | -0.00% | ||
| 1 month | +8.79% | ||
| 3 months | +43.73% | ||
| 6 months | +55.80% | ||
| Current year | +69.16% |
| 1 week | 141.95 |  | 150.34 |
| 1 month | 135.39 | | 160.81 |
| Current year | 77 | | 160.81 |
| 1 year | 54.5 | | 160.81 |
| 3 years | 13.72 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/08/26 | Exercice | Chief Executive Officer | 102,717 | 0.1597% | ||
| 10/06/26 | Exercice | Director | 27,000 | 0.0420% | ||
| 29/05/26 | Exercice | Director | 27,000 | 0.0420% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | +2.37% | +147.89% | +654.96% | 9.63B | |
| -2.35% | -2.54% | -1.59% | +14.88% | 50.35B | |
| -0.85% | +0.66% | +437.23% | +521.10% | 45.2B | |
| -2.00% | +1.14% | +43.82% | +19.85% | 44.71B | |
| -0.90% | -2.22% | +12.50% | +75.05% | 41.24B | |
| +0.43% | -2.20% | +14.55% | +49.08% | 33.08B | |
| -1.54% | +7.62% | - | - | 17.81B | |
| -0.56% | -2.04% | +21.99% | +121.95% | 16.56B | |
| -0.68% | +0.83% | +16.22% | +28.41% | 14.82B | |
| -1.25% | -1.50% | +76.90% | +40.55% | 14B | |
| Average | -1.06% | -0.18% | +85.50% | +169.54% | 28.74B | |
| Weighted average by Cap. | -1.19% | -0.63% | +95.49% | +145.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 542M 467M 438M 401M 748M 51.26B 754M 5.18B 2.02B 26.2B 2.04B 1.99B 84.37B | 203M 175M 164M 150M 280M 19.23B 283M 1.94B 757M 9.83B 764M 747M 31.65B |
| Net income | 324M 279M 261M 239M 446M 30.61B 450M 3.09B 1.2B 15.64B 1.22B 1.19B 50.37B | -32.12M -27.64M -25.94M -23.73M -44.29M -3.04B -44.64M -307M -119M -1.55B -121M -118M -5B |
| Net Debt | -538M -463M -435M -398M -742M -50.88B -748M -5.14B -2B -26B -2.02B -1.98B -83.74B | -511M -440M -413M -378M -705M -48.31B -710M -4.88B -1.9B -24.69B -1.92B -1.88B -79.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$147.65 | -0.77% | 30,503 |
| 03/09/26 | US$148.80 | +1.86% | 354,191 |
| 02/09/26 | US$146.08 | -0.28% | 561,612 |
| 01/09/26 | US$146.49 | -0.85% | 534,144 |
| 31/08/26 | US$147.75 | +2.37% | 567,395 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
